Sernova Biotherapeutics (SEOVF) to Announce Earnings on Thursday

Sernova Biotherapeutics (OTCMKTS:SEOVF) is anticipated to announce its resultson Thursday, September 10th. Analysts expect Sernova Biotherapeutics to announce earnings of ($0.0029) per share for the quarter.

Sernova Biotherapeutics (OTCMKTS:SEOVF) last issued its quarterly earnings data on Thursday, June 11th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01).

Sernova Biotherapeutics Price Performance

OTCMKTS SEOVF opened at $0.08 on Tuesday. The firm has a 50-day moving average price of $0.08 and a two-hundred day moving average price of $0.10. Sernova Biotherapeutics has a 12-month low of $0.07 and a 12-month high of $0.15. The company has a market capitalization of $30.66 million, a P/E ratio of -2.03 and a beta of 0.86.

Sernova Biotherapeutics Company Profile

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.